openPR Logo
Press release

Liver Disease Therapeutics Market to Reach USD 34.78 Billion by 2030, Growing at a 7.4% CAGR

01-20-2025 10:53 AM CET | Health & Medicine

Press release from: MAXIMIZE MARKET RESEARCH PVT. LTD.

Liver Disease Therapeutics Market

Liver Disease Therapeutics Market

๐‹๐ข๐ฏ๐ž๐ซ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ

The liver disease therapeutics market was valued at USD 21.10 billion in 2023 and is projected to reach USD 34.78 billion by 2030, growing at a CAGR of 7.4% during the forecast period (2024-2030). Innovations in therapeutics and increased awareness about liver health are driving the market forward.

The global liver disease therapeutics market is experiencing significant growth, fueled by rising cases of liver diseases and advancements in medical treatments. This press release delves into the market's CAGR details, market size, key country-specific data, and major developments, providing a comprehensive analysis for stakeholders.

๐“๐จ ๐ฅ๐ž๐š๐ซ๐ง ๐ฆ๐จ๐ซ๐ž, ๐ฌ๐ข๐ฆ๐ฉ๐ฅ๐ฒ ๐œ๐ฅ๐ข๐œ๐ค ๐จ๐ง ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค :https://www.maximizemarketresearch.com/request-sample/229296/

Country-Specific Analysis

๐•๐ข๐ž๐ญ๐ง๐š๐ฆ: ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐‹๐ข๐ฏ๐ž๐ซ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ

Vietnam is witnessing an increase in investments in healthcare infrastructure. Recent acquisitions by Pharmacity and collaborations with local biotech firms are paving the way for advanced liver disease therapies. The market in Vietnam is poised for steady growth, driven by government initiatives.

๐“๐ก๐š๐ข๐ฅ๐š๐ง๐: ๐‹๐ข๐ฏ๐ž๐ซ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐†๐ซ๐จ๐ฐ๐ญ๐ก

Thailand's market for liver disease treatments is growing due to a surge in non-alcoholic fatty liver disease (NAFLD) cases. Companies like Bangkok Dusit Medical Services are actively expanding their research and treatment facilities, making significant contributions to market consolidation.

๐‰๐š๐ฉ๐š๐ง: ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐‹๐ข๐ฏ๐ž๐ซ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ

Japan's advancements in regenerative medicine are influencing the liver disease therapeutics market. Collaborations between firms like Takeda Pharmaceutical and research institutions are accelerating innovations in treatments for chronic liver diseases.

๐“๐จ ๐ฅ๐ž๐š๐ซ๐ง ๐ฆ๐จ๐ซ๐ž, ๐ฌ๐ข๐ฆ๐ฉ๐ฅ๐ฒ ๐œ๐ฅ๐ข๐œ๐ค ๐จ๐ง ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค :https://www.maximizemarketresearch.com/request-sample/229296/

๐‚๐ก๐ข๐ง๐š: ๐‚๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐‹๐ข๐ฏ๐ž๐ซ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ

China dominates the liver disease therapeutics market in Asia, thanks to a strong focus on biotechnology and pharmaceutical developments. Major players such as Sinopharm are investing in R&D, driving significant market consolidation.

๐’๐จ๐ฎ๐ญ๐ก ๐Š๐จ๐ซ๐ž๐š: ๐‹๐ข๐ฏ๐ž๐ซ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐”๐ฉ๐๐š๐ญ๐ข๐จ๐ง

South Korea is rapidly adopting cutting-edge technologies in liver therapeutics. Companies like Celltrion are leading clinical trials for advanced treatments, emphasizing biopharmaceutical solutions.

๐’๐ข๐ง๐ ๐š๐ฉ๐จ๐ซ๐ž: ๐‹๐ข๐ฏ๐ž๐ซ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ

Singapore's robust healthcare ecosystem supports the growth of liver disease treatments. With firms like Singapore Biotech spearheading research in novel therapies, the market continues to attract global investors.

๐“๐จ ๐ฅ๐ž๐š๐ซ๐ง ๐ฆ๐จ๐ซ๐ž, ๐ฌ๐ข๐ฆ๐ฉ๐ฅ๐ฒ ๐œ๐ฅ๐ข๐œ๐ค ๐จ๐ง ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค :https://www.maximizemarketresearch.com/request-sample/229296/

๐”๐’: ๐“๐ซ๐ž๐ง๐๐ฌ ๐š๐ง๐ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐‹๐ข๐ฏ๐ž๐ซ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ

The US remains a leader in the liver disease therapeutics market, with significant investments in clinical trials. Companies like Gilead Sciences and AbbVie are advancing the development of therapies for hepatitis and cirrhosis, ensuring consistent market growth.

๐„๐ฎ๐ซ๐จ๐ฉ๐ž: ๐‚๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐š๐ญ๐ข๐จ๐ง ๐š๐ง๐ ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐‹๐ข๐ฏ๐ž๐ซ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ

Europe's liver disease therapeutics market is characterized by strategic mergers and acquisitions. Firms like Sanofi and Novartis are focusing on precision medicine, while collaborations with academic institutions drive innovation.

๐Š๐ž๐ฒ ๐‘๐ž๐œ๐ž๐ง๐ญ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ๐ฌ

Gilead Sciences expanded its clinical trials for hepatitis C treatments in 2024, enhancing its pipeline portfolio.

AbbVie announced its partnership with European research centers to develop novel treatments for liver fibrosis.

Sinopharm launched a new biosimilar drug targeting liver diseases, strengthening its foothold in the Asia-Pacific region.

Takeda Pharmaceutical introduced its latest drug for autoimmune liver disorders in the Japanese market.

Celltrion completed Phase III trials for a breakthrough treatment targeting non-alcoholic steatohepatitis (NASH).

๐…๐จ๐ซ ๐š ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐จ๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ, ๐œ๐ฅ๐ข๐œ๐ค ๐จ๐ง ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ž๐:https://www.maximizemarketresearch.com/market-report/liver-disease-therapeutics-market/229296/

๐‹๐ข๐ฏ๐ž๐ซ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง

๐›๐ฒ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐“๐ฒ๐ฉ๐ž

Antiviral Drugs
Immunosuppressant
Vaccines
Immunoglobulin
Corticosteroids
Targeted Therapy
Chemotherapy

๐›๐ฒ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ฒ๐ฉ๐ž

Hepatitis
Autoimmune Diseases
Non-alcoholic Fatty Liver Disease (NAFLD)
Cancer
Genetic Disorders

๐‹๐ข๐ฏ๐ž๐ซ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ

1. Johnson & Johnson Services Inc.
2. F. Hoffmann-La Roche Ltd.
3. Pfizer Inc.
4. Abbott Laboratories
5. Novartis AG
6. Eli Lilly and Company
7. Gilead Sciences
8. Bristol Myers Squibb
9. AbbVie Inc.
10. Zydus Pharmaceuticals Inc.
11. Intercept Pharmaceuticals, Inc.
12. Merck & Co., Inc.
13. Bristol-Myers Squibb Company
14. Johnson & Johnson
15. Takeda Pharmaceutical Company Limited
16. Eli Lilly and Company
17. Astellas Pharma Inc., Bristol-Myers Squibb
18. GlaxoSmithKline Plc,
19. Merck & Co. Inc.
20. Sanofi S.A
21. Takeda Pharmaceutical
22. Valeant Pharmaceuticals
23. Watson Pharmaceuticals Inc.
24. Theratechnologies Inc.
25. Alnylam Pharmaceuticals Inc.
26. Protagonist Therapeutics Inc.
27. Dicerna Pharmaceuticals Inc.
28. Endo International
29. Provectus Biopharmaceuticals Inc.
30. MAX BioPharma Inc.
31. Achillion Pharmaceuticals
32. Actavis Pharma Inc
33. Alkermes Plc
34. Antipodean Pharmaceuticals
35. Bayer Healthcare Pharmaceuticals
36. Biotest Pharma GmbH
37. Bristol-Myers Squibb Company
38. Conatus Pharmaceuticals

๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ ๐–๐ก๐š๐ญ'๐ฌ ๐“๐ซ๐ž๐ง๐๐ข๐ง๐ :

โ™ฆ Hose Reel Market https://www.maximizemarketresearch.com/market-report/hose-reel-market/78645/

โ™ฆ Ice Cream Machine Market https://www.maximizemarketresearch.com/market-report/ice-cream-machine-market/78649/

โ™ฆ Industrial Automation Oil Gas Market https://www.maximizemarketresearch.com/market-report/industrial-automation-oil-gas-market/152501/

โ™ฆ Industrial Grippers Market https://www.maximizemarketresearch.com/market-report/industrial-grippers-market/77933/

โ™ฆ Industrial Palletizing Robots Market https://www.maximizemarketresearch.com/market-report/industrial-palletizing-robots-market/77409/

โ™ฆ Marine Fire Fighting Equipment Market https://www.maximizemarketresearch.com/market-report/marine-fire-fighting-equipment-market/76737/

โ™ฆ Orbital Sanders Market https://www.maximizemarketresearch.com/market-report/orbital-sanders-market/75450/

โ™ฆ Personal Safety Alarms Market https://www.maximizemarketresearch.com/market-report/personal-safety-alarms-market/148479/

โ™ฆ Photodynamic Therapy Market https://www.maximizemarketresearch.com/market-report/photodynamic-therapy-market/45186/

โ™ฆ Plug Valve Market https://www.maximizemarketresearch.com/market-report/plug-valve-market/78257/

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

๐€๐›๐จ๐ฎ๐ญ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Liver Disease Therapeutics Market to Reach USD 34.78 Billion by 2030, Growing at a 7.4% CAGR here

News-ID: 3822345 • Views: โ€ฆ

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a Robust 13.71% CAGR
09-05-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a โ€ฆ
Bangladesh Ceramics Tiles Market size was valued at USD 882.56 Million in 2023 and the total Bangladesh Ceramics Tiles Market revenue is expected to grow at a CAGR of 13.71 % from 2024 to 2030, reaching nearly USD 2169.38 Million. Bangladesh Ceramics Tiles Market Overview: The Bangladesh ceramics tiles market is a vital component of the country's construction and building materials industry, driven by rapid urbanization, infrastructure development, and rising disposable incomes.โ€ฆ
Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
09-05-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
Furfural Market size was valued at USD 630.2Mn in 2023. The Furfural Market revenue is growing at a CAGR of 6.8 % from 2023 to 2029, reaching nearly USD 998.30 Bn by 2030. Furfural Market Overview: The furfural market is centered around an organic compound derived primarily from agricultural byproducts such as corn cobs, sugarcane bagasse, and rice husks through a process of acid hydrolysis. As one of the oldest renewable chemicals,โ€ฆ
Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to Grow at a 5.59% CAGR Through 2032
09-05-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to โ€ฆ
Chemical Protective Clothing Market size was valued at USD 1.57 Billion in 2024 and the total Chemical Protective Clothing revenue is expected to grow at a CAGR of 5.59% from 2025 to 2032, reaching nearly USD 2.42 Billion. Chemical Protective Clothing Market Overview: The Chemical Protective Clothing (CPC) market comprises garments and accessories specifically designed to shield workers from exposure to hazardous chemicals, liquids, and particulate matter across a wide range ofโ€ฆ
Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR Growth to 2032
09-05-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR โ€ฆ
Prefabricated Homes Market size was valued at USD 18.58 Billion in 2024 and the total Prefabricated Homes revenue is expected to grow at a CAGR of 6.19% from 2025 to 2032, reaching nearly USD 30.04 Billion. Prefabricated Homes Market Overview: The prefabricated homes market, also known as modular or off-site construction, involves the manufacturing of building components in a controlled factory environment before their assembly at the final location. This method revolutionizesโ€ฆ

All 5 Releases


More Releases for Pharma

09-16-2024 | Advertising, Media Consulting, โ€ฆ
Market Research Intellect
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USDย 22.32ย Billion by 2024. The valuation is expected to reach USDย 47.79ย Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of theโ€ฆ
07-22-2024 | Advertising, Media Consulting, โ€ฆ
Market Research Intellect
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingโ€ฆ
07-18-2024 | Advertising, Media Consulting, โ€ฆ
Market Research Intellect
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asโ€ฆ
06-21-2024 | Business, Economy, Finances, B โ€ฆ
ABNewswire
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh โ€ฆ
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theโ€ฆ
02-22-2022 | Health & Medicine
INFINITY BUSINESS INSIGHTS
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, โ€ฆ
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoringโ€ฆ
05-13-2020 | Health & Medicine
Business Industry Reports
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 โ€ฆ
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about theโ€ฆ